Cargando…
Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX)
In the FIGHTDIGO study, digestive cancer patients with dynapenia experienced more chemotherapy-induced neurotoxicities. FIGHTDIGOTOX aimed to evaluate the relationship between pre-therapeutic handgrip strength (HGS) and chemotherapy-induced dose-limiting toxicity (DLT) or all-grade toxicity in diges...
Autores principales: | Martin, Pierre, Botsen, Damien, Brugel, Mathias, Bertin, Eric, Carlier, Claire, Mahmoudi, Rachid, Slimano, Florian, Perrier, Marine, Bouché, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654937/ https://www.ncbi.nlm.nih.gov/pubmed/36364711 http://dx.doi.org/10.3390/nu14214448 |
Ejemplares similares
-
Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapy
por: Moreau, Johanna, et al.
Publicado: (2019) -
Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)
por: Le Bozec, Antoine, et al.
Publicado: (2023) -
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
por: Botsen, Damien, et al.
Publicado: (2018) -
Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients
por: Callon, Sidonie, et al.
Publicado: (2023) -
Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis
por: Laures, Nicolas, et al.
Publicado: (2022)